Literature DB >> 7924224

Ribotyping differentiates relapse from reinfection in the treatment failures of Escherichia coli urinary tract infections in children.

E Bingen1, M Rangaraj, C Safran.   

Abstract

Analysis of restriction fragment-length polymorphism of ribosomal DNA regions (ribotypes) was used as an epidemiologic tool to compare 25 pre- and posttreatment strains obtained from 12 patients treated with either cefpodoxime proxetil or amoxicillin-clavulanic acid. Ribotyping is a promising method to differentiate relapse from reinfection in the treatment failures of Escherichia coli urinary tract infections.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7924224     DOI： 10.1016/0732-8893(94)90030-2

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  3 in total

1.  Comparison of an automated ribotyping system to restriction endonuclease analysis and pulsed-field gel electrophoresis for differentiating vancomycin-resistant Enterococcus faecium isolates.

Authors:  Connie S Price; Holly Huynh; Suzanne Paule; Richard J Hollis; Gary A Noskin; Michael A Pfaller; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women.

Authors:  Karen Ejrnaes; Dorthe Sandvang; Bettina Lundgren; Sven Ferry; Stig Holm; Tor Monsen; Rolf Lundholm; Niels Frimodt-Moller
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

3.  Persistence of Escherichia coli clones and phenotypic and genotypic antibiotic resistance in recurrent urinary tract infections in childhood.

Authors:  Siiri Kõljalg; Kai Truusalu; Inga Vainumäe; Jelena Stsepetova; Epp Sepp; Marika Mikelsaar
Journal:  J Clin Microbiol       Date:  2008-10-29       Impact factor: 5.948
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.